SUNRUN INC (RUN)

US86771W1053 - Common Stock

9.89  -1.02 (-9.35%)

After market: 9.91 +0.02 (+0.2%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RUN. RUN was compared to 91 industry peers in the Electrical Equipment industry. Both the profitability and financial health of RUN have multiple concerns. RUN is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year RUN has reported negative net income.
In the past year RUN has reported a negative cash flow from operations.
In multiple years RUN reported negative net income over the last 5 years.
RUN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

RUN has a Return On Assets of -1.73%. This is in the better half of the industry: RUN outperforms 62.22% of its industry peers.
RUN has a Return On Equity of -7.25%. This is in the better half of the industry: RUN outperforms 61.11% of its industry peers.
Industry RankSector Rank
ROA -1.73%
ROE -7.25%
ROIC N/A
ROA(3y)-2.48%
ROA(5y)-1.64%
ROE(3y)-9.79%
ROE(5y)-5.9%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

RUN has a worse Gross Margin (13.02%) than 63.33% of its industry peers.
RUN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for RUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.06%
GM growth 5Y-24.6%

1

2. Health

2.1 Basic Checks

RUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RUN has been increased compared to 1 year ago.
RUN has more shares outstanding than it did 5 years ago.
RUN has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.01, we must say that RUN is in the distress zone and has some risk of bankruptcy.
RUN has a Altman-Z score (0.01) which is comparable to the rest of the industry.
RUN has a Debt/Equity ratio of 2.33. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.33, RUN is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF N/A
Altman-Z 0.01
ROIC/WACCN/A
WACC5.9%

2.3 Liquidity

RUN has a Current Ratio of 1.47. This is a normal value and indicates that RUN is financially healthy and should not expect problems in meeting its short term obligations.
RUN has a worse Current ratio (1.47) than 70.00% of its industry peers.
RUN has a Quick Ratio of 1.15. This is a normal value and indicates that RUN is financially healthy and should not expect problems in meeting its short term obligations.
RUN has a Quick ratio of 1.15. This is comparable to the rest of the industry: RUN outperforms 43.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.15

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.91% over the past year.
The Revenue for RUN has decreased by -13.46% in the past year. This is quite bad
The Revenue has been growing by 24.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)66.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.48%
Revenue 1Y (TTM)-13.46%
Revenue growth 3Y34.82%
Revenue growth 5Y24.35%
Sales Q2Q%-4.62%

3.2 Future

Based on estimates for the next years, RUN will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.84% on average per year.
RUN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.39% yearly.
EPS Next Y97.03%
EPS Next 2Y38.19%
EPS Next 3Y25.22%
EPS Next 5Y17.84%
Revenue Next Year-7.74%
Revenue Next 2Y3.2%
Revenue Next 3Y7%
Revenue Next 5Y11.39%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RUN. In the last year negative earnings were reported.
Also next year RUN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as RUN's earnings are expected to grow with 25.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.19%
EPS Next 3Y25.22%

0

5. Dividend

5.1 Amount

RUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SUNRUN INC

NASDAQ:RUN (11/15/2024, 8:00:01 PM)

After market: 9.91 +0.02 (+0.2%)

9.89

-1.02 (-9.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.22B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.73%
ROE -7.25%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 13.02%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.47
Quick Ratio 1.15
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)66.91%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y97.03%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.46%
Revenue growth 3Y34.82%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y